Zanteris

Zanteris

Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Zanteris is a Paris-based, privately-held consultancy firm that provides specialized Clinical Project and Vendor Management services to biotech and pharmaceutical companies. Founded and led by a seasoned clinical operations expert, the company leverages deep industry experience and an extensive CRO network to help clients navigate complex clinical trials from RFP to Clinical Study Report (CSR). Its business model is purely service-based, focusing on optimizing resource allocation, mitigating risks, and ensuring regulatory compliance to drive successful trial outcomes for its clients, particularly in oncology and broader drug development.

Oncology

Technology Platform

A service methodology and consultancy model built on 15+ years of clinical operations experience, emphasizing leadership, proven project management techniques, and an extensive network of CROs and freelance consultants to optimize clinical trial execution for clients.

Opportunities

The growing complexity of clinical trials and the trend for biotechs to outsource operational functions create sustained demand for niche expertise in project and vendor management.
Specialization in oncology, a high-growth therapeutic area with complex trials, offers a focused and valuable market segment.

Risk Factors

The business faces significant key-person risk centered on its founder and intense competition from larger CROs and other consultants.
Its boutique, high-touch model may also present challenges to scaling the business effectively.

Competitive Landscape

Zanteris competes with large global CROs that offer full-service project management, smaller niche consulting firms, and a vast pool of independent consultants. Its differentiation lies in its personalized, leadership-focused approach and deep vendor management expertise, targeting biotechs that desire a strategic partner rather than a large, impersonal service provider.